Some patients with skin and allergological disorders can not be optimally treated with the therapies available to date.

The DERMATOLOGIKUM is committed to scientific research and the development of new therapy treatments in allergology, dermatology and aesthetics and works together with various worldwide renowned universities and research institutions in this field such as the research institution SCIderm. Patients can benefit from already having access to a therapy of tomorrow, today. The basis for participating in a clinical trial is an extensive consultation on potential benefits and risks and a thorough care by experienced study physicians.

Please consult your doctor for information on current studies or visit www.sciderm.com or call +49 (0)40 55 44 010.